Focused Investors LLC Has $216.78 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Focused Investors LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 413,900 shares of the healthcare conglomerate's stock after selling 12,700 shares during the quarter. UnitedHealth Group accounts for 7.0% of Focused Investors LLC's holdings, making the stock its 3rd biggest position. Focused Investors LLC's holdings in UnitedHealth Group were worth $216,780,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. Citizens National Bank Trust Department increased its stake in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH increased its stake in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $515,000. Full Sail Capital LLC boosted its position in UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after acquiring an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $39,413,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 1.4%

Shares of UnitedHealth Group stock opened at $303.81 on Monday. The business has a fifty day simple moving average of $314.52 and a two-hundred day simple moving average of $439.94. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a market capitalization of $275.60 billion, a price-to-earnings ratio of 12.72, a P/E/G ratio of 1.46 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.91%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director directly owned 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 in the last ninety days. Insiders own 0.28% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on UNH shares. Mizuho reduced their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. UBS Group reduced their price target on UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a research report on Wednesday, June 25th. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Finally, Piper Sandler decreased their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday, June 3rd. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.